Successful Treatment of Refractory Extensive Pityriasis Rubra Pilaris With Risankizumab and Acitretin
Cutis · 2024
DOI: 10.12788/cutis.1096 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cutis, 2024. Verfasst von Krystina Khalil und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drs. Khalil and Hamburger are from Larkin Community Hospital Palm Springs Campus, Hialeah, Florida. Dr. Hirt is from Larkin Community Hospital South …. Hauptthemen laut MEDLINE: Pityriasis Rubra Pilaris, Acitretin, Keratolytic Agents, Antibodies, Monoclonal.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Drs. Khalil and Hamburger are from Larkin Community Hospital Palm Springs Campus, Hialeah, Florida. Dr. Hirt is from Larkin Community Hospital South Miami Campus, Florida. Dr. Kerdel is from Florida Academic Dermatology…
Zitieren
APA
Khalil, K., Hamburger, N., Hirt, P. A., & Kerdel, F. (2024). Successful Treatment of Refractory Extensive Pityriasis Rubra Pilaris With Risankizumab and Acitretin. Cutis. https://doi.org/10.12788/cutis.1096
Vancouver
Khalil K, Hamburger N, Hirt PA, Kerdel F. Successful Treatment of Refractory Extensive Pityriasis Rubra Pilaris With Risankizumab and Acitretin. Cutis. 2024. doi:10.12788/cutis.1096
BibTeX
@article{Khalil2024,
author = {Khalil, Krystina and Hamburger, Nicole and Hirt, Penelope Alexandra and Kerdel, Francisco},
title = {Successful Treatment of Refractory Extensive Pityriasis Rubra Pilaris With Risankizumab and Acitretin},
journal = {Cutis},
year = {2024},
doi = {10.12788/cutis.1096}
}
EUVIMED